Sabra Healthcare REIT (NASDAQ:SBRA) Sets New 1-Year High – Still a Buy?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) reached a new 52-week high during trading on Tuesday . The company traded as high as $22.77 and last traded at $22.6080, with a volume of 68423 shares changing hands. The stock had previously closed at $22.39.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on SBRA. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Truist Financial upped their price target on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Citigroup reaffirmed a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. UBS Group set a $25.00 target price on Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.25.

Sabra Healthcare REIT Stock Performance

The firm has a market capitalization of $5.56 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 1.72 and a beta of 0.65. The firm has a 50 day moving average price of $19.75 and a 200-day moving average price of $19.90. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the previous year, the firm posted $0.37 EPS. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. As a group, sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Institutional Trading of Sabra Healthcare REIT

A number of large investors have recently made changes to their positions in the company. Wedge Capital Management L L P NC lifted its stake in Sabra Healthcare REIT by 12.8% in the second quarter. Wedge Capital Management L L P NC now owns 245,826 shares of the real estate investment trust’s stock worth $4,796,000 after acquiring an additional 27,822 shares during the last quarter. Hennion & Walsh Asset Management Inc. increased its position in shares of Sabra Healthcare REIT by 18.5% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 121,559 shares of the real estate investment trust’s stock valued at $2,372,000 after purchasing an additional 18,954 shares during the last quarter. Versant Capital Management Inc raised its holdings in shares of Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares in the last quarter. Western Wealth Management LLC acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter valued at $294,000. Finally, Pacer Advisors Inc. lifted its position in shares of Sabra Healthcare REIT by 21.4% during the 1st quarter. Pacer Advisors Inc. now owns 35,554 shares of the real estate investment trust’s stock worth $684,000 after purchasing an additional 6,266 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.